{"gao_id": "GAO-23-106570", "published": "2023-07-28T12:00:00Z", "released": "2023-07-28T08:00:00Z", "summary": "In July 2020, we reported that the CARES Act gave the Food and Drug Administration new tools to regulate over-the-counter drugs like sunscreen and cold medicine. It included a provision offering 18 months of exclusive marketing rights for drugs with new uses or innovative active ingredients. As of May 2023, however, no companies had requested approval for over-the-counter drug innovations. FDA is still preparing to...", "title": "Over-the-Counter Drugs: Status of FDA's Implementation of Exclusivity Provisions in the CARES Act", "topics": ["Over-the-counter drugs", "User fees", "Health care", "Consumers", "Federal rulemaking", "Drugs", "Business Regulation and Consumer Protection", "Access to health care", "Prescription drugs", "Social media", "Educational standards"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-23-106570", "versions": [{"title": "Full Report (9 pages)", "url": "https://www.gao.gov/assets/gao-23-106570.pdf"}, {"title": "Accessible PDF (6 pages)", "url": "https://www.gao.gov/assets/830/828025.pdf"}]}